Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2010 - 2026)

Orthofix Medical (OFIX) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $13.5 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 60.81% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $56.4 million (down 29.19% YoY), and the FY2025 full-year result was $77.3 million, up 28.74% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $13.5 million, up from $13.1 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $34.4 million in Q1 2025 and bottomed at $6.5 million in Q2 2022.
• A 5-year average of $13.7 million and a median of $13.3 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 131.67% in 2025 and slumped 60.81% in 2026, its largest moves.
• Tracing OFIX's Depreciation & Amortization (CF) over 5 years: stood at $7.4 million in 2022, then soared by 88.24% to $14.0 million in 2023, then advanced by 14.5% to $16.0 million in 2024, then decreased by 18.23% to $13.1 million in 2025, then increased by 3.17% to $13.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $13.5 million, $13.1 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison